Status:
UNKNOWN
Microneedle and Trichloroaceticacid in Treatment of Melasma
Lead Sponsor:
Assiut University
Conditions:
Melasma
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Melasma is an acquired disorder of hyperpigmentation characterised by blotchy, light-to-dark brown macules distributed symmetrically on the sun-exposed parts of the body. Although many factors have b...
Detailed Description
As regards management, the therapeutic options range from photoprotection, topical hypopigmenting agents, chemical peels and lasers. There are variety of less-tried systemic agents like fish oil, gree...
Eligibility Criteria
Inclusion
- Both sex will be included Age range from 18- 50 yrs.' old Patients with realistic expectations.
Exclusion
- patients taking oral contraceptive pills. patients with history of polycystic ovary. pregnant and lactating females. patients with active infection. patients on isotretinoin. patients with history of keloids,or hypertrophic scars.
Key Trial Info
Start Date :
April 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 5 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03472235
Start Date
April 5 2018
End Date
April 5 2020
Last Update
March 21 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.